Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua S Mytych

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Cellular Immunology|October 28, 2021
Efferocytosis and Anthrax: Implications for Bacterial Sepsis?Joshua S Mytych, Zijian Pan, A Darise Farris
International Journal of Molecular Sciences|May 27, 2026
Challenges and Innovation for Diagnosing and Treatment of Secondary Progressive Multiple SclerosisEkdanai Uawithya, Joshua S Mytych, Ismail Muwenda, et al.
International Journal of Molecular Sciences|June 12, 2026
Longitudinal and Stability-Aware Analysis Reveals Treatment-Specific MicroRNA Response Signatures Following Immune-Reconstitution and B-Cell-Targeted Therapies in Multiple SclerosisNasar Ata, Joshua S Mytych, Mirela Cerghet, et al.
Frontiers in Immunology|July 14, 2026
Smoking accelerates immunosenescence in multiple sclerosisMeerah Khan, Ekdanai Uawithya, Joshua S Mytych, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Peptidoglycan from <i>Bacillus anthracis</i> Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3Joshua S Mytych, Zijian Pan, Charmaine Lopez-Davis, et al.
Immunohorizons|March 22, 2024
Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3Joshua S Mytych, Zijian Pan, Charmaine Lopez-Davis, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Cellular Immunology|October 28, 2021
Efferocytosis and Anthrax: Implications for Bacterial Sepsis?Joshua S Mytych, Zijian Pan, A Darise Farris
International Journal of Molecular Sciences|May 27, 2026
Challenges and Innovation for Diagnosing and Treatment of Secondary Progressive Multiple SclerosisEkdanai Uawithya, Joshua S Mytych, Ismail Muwenda, et al.
International Journal of Molecular Sciences|June 12, 2026
Longitudinal and Stability-Aware Analysis Reveals Treatment-Specific MicroRNA Response Signatures Following Immune-Reconstitution and B-Cell-Targeted Therapies in Multiple SclerosisNasar Ata, Joshua S Mytych, Mirela Cerghet, et al.
Frontiers in Immunology|July 14, 2026
Smoking accelerates immunosenescence in multiple sclerosisMeerah Khan, Ekdanai Uawithya, Joshua S Mytych, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Peptidoglycan from <i>Bacillus anthracis</i> Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3Joshua S Mytych, Zijian Pan, Charmaine Lopez-Davis, et al.
Immunohorizons|March 22, 2024
Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3Joshua S Mytych, Zijian Pan, Charmaine Lopez-Davis, et al.
Pageof 1